Peanut Allergy Drug Will Protect Children, Experts Tell F.D.A.
The first-ever drug regimen to blunt acute peanut allergies in children should be approved, experts told a Food and Drug Administration committee on Friday, because the therapy has the potential to reduce the risk of life-threatening reactions and to improve patients’ lives. The new drug, called Palforzia and made by Aimmune Therapeutics, is an oral…